Injective might surprise everyone with an 8x 👀
The market is already rewarding two of the clearest narratives across onchain finance with $HYPE becoming a major trading infrastructure bet, while $ONDO made institutional tokenization one of the strongest RWA themes.
I think Injective sits where those narratives begin to overlap, with equities and RWAs trading onchain alongside infrastructure designed for American financial markets.
An 8x sounds aggressive, I know but still, the version of Injective trading today is materially different from the one that reached its previous ATH.
Its position in the U.S. has developed across several fronts:
• Injective is the first L1 to have an SEC-registered transfer agent.
• INJ futures are live on Bitnomial’s CFTC-regulated U.S. exchange.
• Canary Capital has filed for a staked INJ ETF.
Those developments do not guarantee institutional adoption or price appreciation, but they give Injective an actual pathway across tokenization, onchain markets, and regulated access.
For me, the American angle is becoming a major part of the Injective thesis 🔥
#Macro Insights#
The market is already rewarding two of the clearest narratives across onchain finance with $HYPE becoming a major trading infrastructure bet, while $ONDO made institutional tokenization one of the strongest RWA themes.
I think Injective sits where those narratives begin to overlap, with equities and RWAs trading onchain alongside infrastructure designed for American financial markets.
An 8x sounds aggressive, I know but still, the version of Injective trading today is materially different from the one that reached its previous ATH.
Its position in the U.S. has developed across several fronts:
• Injective is the first L1 to have an SEC-registered transfer agent.
• INJ futures are live on Bitnomial’s CFTC-regulated U.S. exchange.
• Canary Capital has filed for a staked INJ ETF.
Those developments do not guarantee institutional adoption or price appreciation, but they give Injective an actual pathway across tokenization, onchain markets, and regulated access.
For me, the American angle is becoming a major part of the Injective thesis 🔥
#Macro Insights#
